Neurocrine Biosciences Inc (NBIX) Com Stk NPV (CDI)
Sell:$138.06Buy:$138.43
$1.65 (1.18%)
NASDAQ:
0.12%
Market closed | Prices delayed by at least 15 minutes0.12%- This stock can be held in a
Stocks and Shares ISASell:$138.06
Buy:$138.43
Change:$1.65 (1.18%)
$1.65 (1.18%)Market closed | Prices delayed by at least 15 minutes
Sell:$138.06
Buy:$138.43
Change:$1.65 (1.18%)
$1.65 (1.18%)Market closed | Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 15 April 2024 | Eric S. BenevichChief Level Officer | Sell Option/Award related | 12,587 | $133.36 | $1,678,660.22 | 40,778 |
| 15 April 2024 | Eric S. BenevichChief Level Officer | Sell Option/Award related | 7,231 | $133.36 | $964,359.42 | 40,778 |
| 1 April 2024 | Ingrid DelaetChief Level Officer | Sell Option/Award related | 272 | $137.30 | $37,345.60 | 7,507 |
| 21 March 2024 | Ingrid DelaetChief Level Officer | Sell Option/Award related | 5,000 | $145.06 | $725,320.00 | 7,507 |
| 14 March 2024 | Eric S. BenevichChief Level Officer | Sell Option/Award related | 5,479 | $139.38 | $763,656.99 | 40,778 |
| 14 March 2024 | Eric S. BenevichChief Level Officer | Sell Option/Award related | 69,521 | $139.38 | $9,689,760.51 | 40,778 |
| 14 March 2024 | George J MorrowIndependent Director | Sell Option/Award related | 20,000 | $139.42 | $2,788,432.00 | 0 |
| 14 March 2024 | George J MorrowIndependent Director | Sell Option/Award related | 20,000 | $139.41 | $2,788,278.00 | 0 |
| 13 March 2024 | Richard F PopsIndependent Director | Sell Option/Award related | 23,200 | $140.33 | $3,255,621.20 | 29,512 |
| 13 March 2024 | Ingrid DelaetChief Level Officer | Sell Option/Award related | 3,000 | $140.14 | $420,419.40 | 7,507 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 8 January 2024 | Kevin Charles GormanCEO | Sell Option/Award related | 105,835 | $132.44 | $14,016,522.81 | 499,754 |
| 14 March 2024 | Eric S. BenevichChief Level Officer | Sell Option/Award related | 69,521 | $139.38 | $9,689,760.51 | 40,778 |
| 2 January 2024 | Kyle W. GanoChief Level Officer | Sell Option/Award related | 68,884 | $131.47 | $9,056,289.69 | 130,250 |
| 9 January 2024 | Kevin Charles GormanCEO | Sell Option/Award related | 62,023 | $134.01 | $8,311,894.50 | 499,754 |
| 28 February 2024 | Eric S. BenevichChief Level Officer | Sell Option/Award related | 53,143 | $134.69 | $7,157,729.70 | 40,616 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.